IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) and Intuitive Surgical (NASDAQ:ISRG – Get Free Report) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, analyst recommendations and risk.
Earnings and Valuation
This table compares IDEXX Laboratories and Intuitive Surgical”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| IDEXX Laboratories | $4.30 billion | 12.73 | $1.06 billion | $14.83 | 46.90 |
| Intuitive Surgical | $10.06 billion | 14.88 | $2.86 billion | $8.27 | 52.23 |
Insider and Institutional Ownership
87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by company insiders. Comparatively, 0.6% of Intuitive Surgical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for IDEXX Laboratories and Intuitive Surgical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| IDEXX Laboratories | 0 | 6 | 7 | 0 | 2.54 |
| Intuitive Surgical | 1 | 5 | 23 | 1 | 2.80 |
IDEXX Laboratories presently has a consensus target price of $717.27, indicating a potential upside of 3.12%. Intuitive Surgical has a consensus target price of $493.54, indicating a potential upside of 14.26%. Given Intuitive Surgical’s stronger consensus rating and higher possible upside, analysts clearly believe Intuitive Surgical is more favorable than IDEXX Laboratories.
Profitability
This table compares IDEXX Laboratories and Intuitive Surgical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| IDEXX Laboratories | 25.36% | 71.04% | 33.99% |
| Intuitive Surgical | 25.54% | 18.17% | 15.73% |
Risk & Volatility
IDEXX Laboratories has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500.
Summary
Intuitive Surgical beats IDEXX Laboratories on 9 of the 15 factors compared between the two stocks.
About IDEXX Laboratories
IDEXX Laboratories develops and sells diagnostic, technology and software products for veterinary, livestock and water-testing markets. Its veterinary offerings include in-clinic diagnostic instruments and tests, reference laboratory services, digital imaging and practice-management software that help veterinary professionals assess animal health and manage their practices. The company also provides diagnostic tests and related services for livestock and poultry, as well as products used to monitor water quality.
About Intuitive Surgical
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
